Background: Tuberculosis is itself a major public health problem in Nepal and the emergence HIV further complicated the issue. Tuberculosis is the most common cause of death among HIV/AIDS patients worldwide. Tuberculosis and HIV co-infection is associated with special diagnostic and ther apeutic challenges and constitutes an immense burden on healthcare system of heavily infected countries like Nepal. Objective: The objective of the study was to determine the prevalence of pulmonary tuberculosis and their immunologic profi les among HIV positive patients. Methods: A hospital based cross-sectional study was conducted from Januray 2012 to July 2012 among adult HIV-positive patients attending ART centers at Seti Zonal Hospital and Mahakali Zonal Hospital. Clinical and laboratory investigations including Acid Fast staining and culture were used to identify tuberculosis cases. Blood samples were collected to determine CD4+ lymphocyte count. A structured questionnaire was used to collect socio-demographic characteristics of study participants. The data was entered and analysed using SPSS version 16 software. Results: A total of 103 HIV positive participants were enrolled. Five (4.9%) of the study participants (three females and two males) were found to have pulmonary tuberculosis. Majority [4(80%)] of TB-HIV co-infection was found in 21-40 years age group. Similarly four (80%) of them were illiterate. Among fi ve TB cases only two cases were detected by direct microscopy. In general it was observed that various clinical manifestations such as cough, chest pain, weight loss, loss of appetite etc. are more common in TB co-infected HIV patients in comparison to non-co-infected counterparts. Similarly, higher percentage of TB cases were seen in patients with low CD4+ count (<500/mm 3 ). Conclusions: We found high prevalence of tuberculosis-HIV co-infection. More such cases were seen among those with low CD4+ cell count. Early detection of co-infection is very necessary to facilitate early ART initiation, thereby strengthening their immune status.
Background and aims: Tuberculosis is still a major public health problem in Nepal. The situation is further worsened by the widespread epidemic of HIV. Knowledge of TB/HIV co-infection is essential for effective dual case management. The objective of this study was to determine the TB/HIV coinfection status among patients visiting antiretroviral therapy centers of Seti Zonal Hospital and Mahakali Zonal Hospital. Methods: A cross sectional study was carried out in the department of Microbiology at Siddhanath Science Campus, Mahendranagar between January 2012 and July 2012. One hundred three patients were randomly selected, and were investigated for tuberculosis by direct microscopy and cultural technique. Socio-demographic features were collected by pre structured questionnaire. Data were entered into SPSS 11.5 and analyzed. Results: Of the 103 people infected with HIV, 46 (44.7%) were males and 57(55.3%) were females. Majority (64.07%) of them were in the productive age group (21-40 years). Forty two (40.8%) of the respondents were not literate. As high as 43.9% of the women were widow and 10.7% of the studied subjects showed mother to child transmission. The overall prevalence of TB among HIV infected people was found to be 4.9%. Among five TB cases only two cases were detected by direct microscopy. Conclusion: The overall prevalence of TB among HIV infected people was found to be 4.9%. Youths of productive age groups with low socioeconomic status were more vulnerable to HIV/AIDS. Culture was found to be more superior method of diagnosis than microscopy. DOI: http://dx.doi.org/10.3126/jaim.v3i1.10696 Journal of Advances in Internal Medicine 2014;03(01):11-16
Background: More than 340 million cases of curable sexually transmitted infections were estimated to have occurred
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.